A detailed history of Franklin Resources Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 194,442 shares of IBRX stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
194,442
Previous 199,181 2.38%
Holding current value
$1.06 Million
Previous $1.26 Million 42.69%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$3.32 - $6.7 $15,733 - $31,751
-4,739 Reduced 2.38%
194,442 $721,000
Q2 2024

Aug 14, 2024

SELL
$4.82 - $9.15 $928,192 - $1.76 Million
-192,571 Reduced 49.16%
199,181 $1.26 Million
Q1 2024

May 13, 2024

BUY
$3.23 - $6.17 $1.27 Million - $2.42 Million
391,752 New
391,752 $2.1 Million
Q4 2021

Feb 11, 2022

SELL
$5.67 - $10.18 $110,565 - $198,510
-19,500 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$9.17 - $14.24 $178,815 - $277,680
19,500 New
19,500 $190,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $2.18B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.